Home LiteratureArticle Details
PMID: 25762330 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Probing the Huntingtin 1-17 membrane anchor on a phospholipid bilayer by using all-atom simulations.

Biophysical journal ·Vol. 108 ·No. 5 ·2015-03-10 ·Pages 1187-98

Côté S, Binette V, Salnikov ES, Bechinger B, Mousseau N

Abstract

Mislocalization and aggregation of the huntingtin protein are related to Huntington's disease. Its first exon-more specifically the first 17 amino acids (Htt17)-is crucial for the physiological and pathological functions of huntingtin. It regulates huntingtin's activity through posttranslational modifications and serves as an anchor to membrane-containing organelles of the cell. Recently, structure and orientation of the Htt17 membrane anchor were determined using a combined solution and solid-state NMR approach. This prompted us to refine this model by investigating the dynamics and thermodynamics of this membrane anchor on a POPC bilayer using all-atom, explicit solvent molecular dynamics and Hamiltonian replica exchange. Our simulations are combined with various experimental measurements to generate a high-resolution atomistic model for the huntingtin Htt17 membrane anchor on a POPC bilayer. More precisely, we observe that the single α-helix structure is more stable in the phospholipid membrane than the NMR model obtained in the presence of dodecylphosphocholine detergent micelles. The resulting Htt17 monomer has its hydrophobic plane oriented parallel to the bilayer surface. Our results further unveil the key residues interacting with the membrane in terms of hydrogen bonds, salt-bridges, and nonpolar contributions. We also observe that Htt17 equilibrates at a well-defined insertion depth and that it perturbs the physical properties-order parameter, thickness, and area per lipid-of the bilayer in a manner that could favor its dimerization. Overall, our observations reinforce and refine the NMR measurements on the Htt17 membrane anchor segment of huntingtin that is of fundamental importance to its biological functions.

MeSH Terms
Amino Acid Sequence Humans Huntingtin Protein Lipid Bilayers/chemistry Molecular Dynamics Simulation Molecular Sequence Data Nerve Tissue Proteins/chemistry,metabolism Peptide Fragments/chemistry Phosphatidylcholines/chemistry Protein Binding Protein Structure, Tertiary
Chemicals
HTT protein, human Huntingtin Protein Lipid Bilayers Nerve Tissue Proteins Peptide Fragments Phosphatidylcholines 1-palmitoyl-2-oleoylphosphatidylcholine
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Côté Sébastien
Département de Physique and Groupe de Recherche sur les Protéines Membranaires, Université de Montréal, Montréal, Québec, Canada. Electronic address: sebastien.cote.4@umontreal.ca.
Binette Vincent
Département de Physique and Groupe de Recherche sur les Protéines Membranaires, Université de Montréal, Montréal, Québec, Canada.
Salnikov Evgeniy S
Université de Strasbourg/Centre National de la Recherche Scientifique, UMR7177, Institut de Chimie, Strasbourg, France.
Bechinger Burkhard
Université de Strasbourg/Centre National de la Recherche Scientifique, UMR7177, Institut de Chimie, Strasbourg, France.
Mousseau Normand
Département de Physique and Groupe de Recherche sur les Protéines Membranaires, Université de Montréal, Montréal, Québec, Canada. Electronic address: normand.mousseau@umontreal.ca.
References (77)
77 references, click to expand
  1. Membrane Protein Simulations Using AMBER Force Field and Berger Lipid Parameters.
    J Chem Theory Comput. 2012 Mar 13;8(3):948-58 PMID: 26593357
  2. The first 17 amino acids of Huntingtin modulate its sub-cellular localization, aggregation and effects on calcium homeostasis.
    Hum Mol Genet. 2007 Jan 1;16(1):61-77 PMID: 17135277
  3. An in vitro perspective on the molecular mechanisms underlying mutant huntingtin protein toxicity.
    Cell Death Dis. 2012;3:e382 PMID: 22932724
  4. Reorientation and dimerization of the membrane-bound antimicrobial peptide PGLa from microsecond all-atom MD simulations.
    Biophys J. 2012 Aug 8;103(3):472-82 PMID: 22947863
  5. Membrane perturbation induced by interfacially adsorbed peptides.
    Biophys J. 2004 Jun;86(6):3607-19 PMID: 15189858
  6. Modulation of polyglutamine conformations and dimer formation by the N-terminus of huntingtin.
    J Mol Biol. 2010 Mar 12;396(5):1295-309 PMID: 20026071
  7. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.
    Science. 1997 Sep 26;277(5334):1990-3 PMID: 9302293
  8. Polyglutamine expansion in huntingtin alters its interaction with phospholipids.
    J Neurochem. 2009 Sep;110(5):1585-97 PMID: 19566678
  9. Amyloidogenic protein-membrane interactions: mechanistic insight from model systems.
    Angew Chem Int Ed Engl. 2010 Aug 2;49(33):5628-54 PMID: 20623810
  10. Contribution of nuclear and extranuclear polyQ to neurological phenotypes in mouse models of Huntington's disease.
    Hum Mol Genet. 2005 Oct 15;14(20):3065-78 PMID: 16183657
  11. GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit.
    Bioinformatics. 2013 Apr 1;29(7):845-54 PMID: 23407358
  12. Molecular understanding of a potential functional link between antimicrobial and amyloid peptides.
    Soft Matter. 2014 Oct 14;10(38):7425-51 PMID: 25105988
  13. Replica exchange with solute scaling: a more efficient version of replica exchange with solute tempering (REST2).
    J Phys Chem B. 2011 Aug 4;115(30):9431-8 PMID: 21714551
  14. Polyglutamine expansion of huntingtin impairs its nuclear export.
    Nat Genet. 2005 Feb;37(2):198-204 PMID: 15654337
  15. Glutamine repeats and neurodegeneration.
    Annu Rev Neurosci. 2000;23:217-47 PMID: 10845064
  16. Slow amyloid nucleation via α-helix-rich oligomeric intermediates in short polyglutamine-containing huntingtin fragments.
    J Mol Biol. 2012 Feb 3;415(5):881-99 PMID: 22178474
  17. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.
    Cell. 1996 Nov 1;87(3):493-506 PMID: 8898202
  18. An N-terminal nuclear export signal regulates trafficking and aggregation of Huntingtin (Htt) protein exon 1.
    J Biol Chem. 2013 Mar 1;288(9):6063-71 PMID: 23319588
  19. Huntingtin as an essential integrator of intracellular vesicular trafficking.
    Trends Cell Biol. 2009 Apr;19(4):147-55 PMID: 19269181
  20. Polyglutamine induced misfolding of huntingtin exon1 is modulated by the flanking sequences.
    PLoS Comput Biol. 2010 Apr;6(4):e1000772 PMID: 20442863
  21. A coarse-grained model for polyglutamine aggregation modulated by amphipathic flanking sequences.
    Biophys J. 2014 Sep 2;107(5):1226-35 PMID: 25185558
  22. Phosphorylation of threonine 3: implications for Huntingtin aggregation and neurotoxicity.
    J Biol Chem. 2009 Oct 23;284(43):29427-36 PMID: 19710014
  23. Trinucleotide repeat disorders.
    Annu Rev Neurosci. 2007;30:575-621 PMID: 17417937
  24. The channel hypothesis of Huntington's disease.
    Brain Res Bull. 2001 Oct-Nov 1;56(3-4):281-4 PMID: 11719262
  25. How robust are protein folding simulations with respect to force field parameterization?
    Biophys J. 2011 May 4;100(9):L47-9 PMID: 21539772
  26. Protein folding: sticky N17 speeds huntingtin pile-up.
    Nat Chem Biol. 2010 Jan;6(1):7-8 PMID: 20016493
  27. A stress sensitive ER membrane-association domain in Huntingtin protein defines a potential role for Huntingtin in the regulation of autophagy.
    Autophagy. 2008 Jan;4(1):91-3 PMID: 17986868
  28. Huntington disease and the huntingtin protein.
    Prog Mol Biol Transl Sci. 2012;107:189-214 PMID: 22482451
  29. Atomistic mechanisms of huntingtin N-terminal fragment insertion on a phospholipid bilayer revealed by molecular dynamics simulations.
    Proteins. 2014 Jul;82(7):1409-27 PMID: 24415136
  30. Tilt and rotational pitch angle of membrane-inserted polypeptides from combined 15N and 2H solid-state NMR spectroscopy.
    Biochemistry. 2004 Aug 17;43(32):10502-12 PMID: 15301548
  31. Amyloid-forming proteins alter the local mechanical properties of lipid membranes.
    Biochemistry. 2013 Feb 5;52(5):808-17 PMID: 23331195
  32. Polyglutamine-induced ion channels: a possible mechanism for the neurotoxicity of Huntington and other CAG repeat diseases.
    J Neurosci Res. 2000 May 15;60(4):490-4 PMID: 10797551
  33. Serines 13 and 16 are critical determinants of full-length human mutant huntingtin induced disease pathogenesis in HD mice.
    Neuron. 2009 Dec 24;64(6):828-40 PMID: 20064390
  34. Polyglutamine disruption of the huntingtin exon 1 N terminus triggers a complex aggregation mechanism.
    Nat Struct Mol Biol. 2009 Apr;16(4):380-9 PMID: 19270701
  35. Perturbation of a lipid membrane by amphipathic peptides and its role in pore formation.
    Eur Biophys J. 2005 May;34(3):230-42 PMID: 15619088
  36. The huntingtin N17 domain is a multifunctional CRM1 and Ran-dependent nuclear and cilial export signal.
    Hum Mol Genet. 2013 Apr 1;22(7):1383-94 PMID: 23297360
  37. Analysis of lipid surface area in protein-membrane systems combining Voronoi tessellation and Monte Carlo integration methods.
    J Comput Chem. 2012 Jan 30;33(3):286-93 PMID: 22102317
  38. LAMBADA and InflateGRO2: efficient membrane alignment and insertion of membrane proteins for molecular dynamics simulations.
    J Chem Inf Model. 2012 Oct 22;52(10):2657-69 PMID: 22989154
  39. The polymorphic nature of membrane-active peptides from biophysical and structural investigations.
    Curr Protein Pept Sci. 2012 Nov;13(7):602-10 PMID: 23116441
  40. Kinetically competing huntingtin aggregation pathways control amyloid polymorphism and properties.
    Biochemistry. 2012 Apr 3;51(13):2706-16 PMID: 22432740
  41. Membrane interactions of the amphipathic amino terminus of huntingtin.
    Biochemistry. 2013 Feb 5;52(5):847-58 PMID: 23305455
  42. Analysis of the amide (15)N chemical shift tensor of the C(alpha) tetrasubstituted constituent of membrane-active peptaibols, the alpha-aminoisobutyric acid residue, compared to those of di- and tri-substituted proteinogenic amino acid residues.
    J Biomol NMR. 2009 Dec;45(4):373-87 PMID: 19823773
  43. Energetics of peptide and protein binding to lipid membranes.
    Adv Exp Med Biol. 2010;677:14-23 PMID: 20687477
  44. Multiple phenotypes in Huntington disease mouse neural stem cells.
    Mol Cell Neurosci. 2012 May;50(1):70-81 PMID: 22508027
  45. History of genetic disease: the molecular genetics of Huntington disease - a history.
    Nat Rev Genet. 2005 Oct;6(10):766-73 PMID: 16136077
  46. Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysis.
    Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12784-9 PMID: 11675509
  47. GridMAT-MD: a grid-based membrane analysis tool for use with molecular dynamics.
    J Comput Chem. 2009 Sep;30(12):1952-8 PMID: 19090582
  48. Knowledge-based protein secondary structure assignment.
    Proteins. 1995 Dec;23(4):566-79 PMID: 8749853
  49. A compact beta model of huntingtin toxicity.
    J Biol Chem. 2011 Mar 11;286(10):8188-96 PMID: 21209075
  50. Improved prediction of protein side-chain conformations with SCWRL4.
    Proteins. 2009 Dec;77(4):778-95 PMID: 19603484
  51. Huntingtin has a membrane association signal that can modulate huntingtin aggregation, nuclear entry and toxicity.
    Hum Mol Genet. 2007 Nov 1;16(21):2600-15 PMID: 17704510
  52. The structural and topological analysis of membrane-associated polypeptides by oriented solid-state NMR spectroscopy: established concepts and novel developments.
    Biophys Chem. 2011 Jan;153(2-3):115-25 PMID: 21145159
  53. GROMACS: fast, flexible, and free.
    J Comput Chem. 2005 Dec;26(16):1701-18 PMID: 16211538
  54. All-atom stability and oligomerization simulations of polyglutamine nanotubes with and without the 17-amino-acid N-terminal fragment of the Huntingtin protein.
    J Phys Chem B. 2012 Oct 11;116(40):12168-79 PMID: 22978784
  55. Investigation of membrane penetration depth and interactions of the amino-terminal domain of huntingtin: refined analysis by tryptophan fluorescence measurement.
    Eur Biophys J. 2014 Sep;43(8-9):347-60 PMID: 24895024
  56. Structure and topology of the huntingtin 1-17 membrane anchor by a combined solution and solid-state NMR approach.
    Biophys J. 2013 Aug 6;105(3):699-710 PMID: 23931318
  57. IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome.
    J Cell Biol. 2009 Dec 28;187(7):1083-99 PMID: 20026656
  58. Huntingtin disrupts lipid bilayers in a polyQ-length dependent manner.
    Biochim Biophys Acta. 2013 Aug;1828(8):1953-61 PMID: 23643759
  59. Secondary structures of native and pathogenic huntingtin N-terminal fragments.
    J Phys Chem B. 2011 Oct 13;115(40):11597-608 PMID: 21910495
  60. Curvature enhances binding and aggregation of huntingtin at lipid membranes.
    Biochemistry. 2014 Apr 15;53(14):2355-65 PMID: 24670006
  61. The effects of flanking sequences in the interaction of polyglutamine peptides with a membrane bilayer.
    J Phys Chem B. 2014 Jun 19;118(24):6368-79 PMID: 24354677
  62. Conformations of the Huntingtin N-term in aqueous solution from atomistic simulations.
    FEBS Lett. 2011 Oct 3;585(19):3086-9 PMID: 21889504
  63. Physical chemistry of polyglutamine: intriguing tales of a monotonous sequence.
    J Mol Biol. 2012 Aug 24;421(4-5):466-90 PMID: 22306404
  64. SUMO modification of Huntingtin and Huntington's disease pathology.
    Science. 2004 Apr 2;304(5667):100-4 PMID: 15064418
  65. Identification of novel potentially toxic oligomers formed in vitro from mammalian-derived expanded huntingtin exon-1 protein.
    J Biol Chem. 2012 May 4;287(19):16017-28 PMID: 22433867
  66. The predicted structure of the headpiece of the Huntingtin protein and its implications on Huntingtin aggregation.
    J Mol Biol. 2009 May 22;388(5):919-27 PMID: 19361448
  67. Poly-L-glutamine forms cation channels: relevance to the pathogenesis of the polyglutamine diseases.
    Biophys J. 2000 Jun;78(6):2892-9 PMID: 10827970
  68. Are amyloid diseases caused by protein aggregates that mimic bacterial pore-forming toxins?
    Q Rev Biophys. 2006 May;39(2):167-201 PMID: 16978447
  69. Inactivation of the mouse Huntington's disease gene homolog Hdh.
    Science. 1995 Jul 21;269(5222):407-10 PMID: 7618107
  70. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation.
    Cell. 1997 Aug 8;90(3):537-48 PMID: 9267033
  71. The interaction of polyglutamine peptides with lipid membranes is regulated by flanking sequences associated with huntingtin.
    J Biol Chem. 2013 May 24;288(21):14993-5005 PMID: 23572526
  72. Kinase inhibitors modulate huntingtin cell localization and toxicity.
    Nat Chem Biol. 2011 Jul;7(7):453-60 PMID: 21623356
  73. Secondary structure of Huntingtin amino-terminal region.
    Structure. 2009 Sep 9;17(9):1205-12 PMID: 19748341
  74. Huntingtin associates with acidic phospholipids at the plasma membrane.
    J Biol Chem. 2005 Oct 28;280(43):36464-73 PMID: 16085648
  75. Diseases of unstable repeat expansion: mechanisms and common principles.
    Nat Rev Genet. 2005 Oct;6(10):743-55 PMID: 16205714
  76. N-terminal proteolysis of full-length mutant huntingtin in an inducible PC12 cell model of Huntington's disease.
    Cell Cycle. 2007 Dec 1;6(23):2970-81 PMID: 18156806
  77. GROMACS 4:  Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation.
    J Chem Theory Comput. 2008 Mar;4(3):435-47 PMID: 26620784
Article Info
Journal
Biophysical journal
Abbr.
Biophys J
ISSN
1542-0086
Published
2015-03-10
Pages
1187-98
Language
English
Region
United States
NLM ID
0370626
PMCID
PMC4375615
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com